Melanie J. Mackean

Edinburgh, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Clinicopathological conference: a pregnant woman with headache and migratory sensory symptoms.

Clinicopathological conference: a pregnant woman with headache and migratory sensory symptoms.

Journal: Practical neurology

Published: January 01, 2026

Divergent trajectories to structural diversity impact patient survival in high grade serous ovarian cancer.

Divergent trajectories to structural diversity impact patient survival in high grade serous ovarian cancer.

Journal: Nature communications

Published: October 03, 2024

Validation of the Scottish Inflammatory Prognostic Score (SIPS) in NSCLC Patients Treated with First-Line Pembrolizumab.

Validation of the Scottish Inflammatory Prognostic Score (SIPS) in NSCLC Patients Treated with First-Line Pembrolizumab.

Journal: Cancers

Published: September 30, 2024

Early prehabilitation reduces admissions and time in hospital in patients with newly diagnosed lung cancer.

Early prehabilitation reduces admissions and time in hospital in patients with newly diagnosed lung cancer.

Journal: BMJ supportive & palliative care

Published: March 07, 2024

Immune-Related Adverse Events, Biomarkers of Systemic Inflammation, and Survival Outcomes in Patients Receiving Pembrolizumab for Non-Small-Cell Lung Cancer.

Immune-Related Adverse Events, Biomarkers of Systemic Inflammation, and Survival Outcomes in Patients Receiving Pembrolizumab for Non-Small-Cell Lung Cancer.

Journal: Cancers

Published: October 12, 2023

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study.

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 22, 2023

Prehabilitation Reduces Hospital Admissions for Patients With Advanced Lung Cancer.

Prehabilitation Reduces Hospital Admissions for Patients With Advanced Lung Cancer.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: September 21, 2023

Early prehabilitation in suspected locally advanced and metastatic lung cancer.

Early prehabilitation in suspected locally advanced and metastatic lung cancer.

Journal: BMJ supportive & palliative care

Published: May 01, 2023

Prognostic value of the Scottish Inflammatory prognostic Score in patients with NSCLC expressing PD-L1 ≥ 50 % progressing on first-line pembrolizumab.

Prognostic value of the Scottish Inflammatory prognostic Score in patients with NSCLC expressing PD-L1 ≥ 50 % progressing on first-line pembrolizumab.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: March 23, 2023

Comment on: Prehabilitation and Rehabilitation for Patients with Lung Cancer: A Review of Where We are Today.

Comment on: Prehabilitation and Rehabilitation for Patients with Lung Cancer: A Review of Where We are Today.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: January 30, 2023

Defining the road map to a UK national lung cancer screening programme.

Defining the road map to a UK national lung cancer screening programme.

Journal: The Lancet. Oncology

Published: January 06, 2023

Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre.

Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre.

Journal: Cancers

Published: December 12, 2022

Showing 1-12 of 33

Last Updated: 09/26/2026